ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AstraZeneca and Ionis Sign Deal to Develop and Commercialize Eplontersen
December 09, 2021AstraZeneca has entered into a new global development and commercialization agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-LRX. -
AstraZeneca and Ionis partner to develop antisense therapy eplontersen
December 09, 2021AstraZeneca and Ionis Pharmaceuticals have signed an agreement to develop and market experimental therapy, eplontersen, previously called IONIS-TTR-LRX. -
Ionis, AstraZeneca Partner to Develop and Commercialize Eplontersen
December 08, 2021Will develop a global strategy for developing, manufacturing and commercializing eplontersen, an antisense medicine to treat transthyretin amyloidosis.
Pharma Sources Insight January 2025
